INS and Hyperglycemia: Two-thirds (68.6%, n = 35) of infants had high blood pressure during BTM treatment, but none required anti-hypertensive treatment; 15.7% (n = 8) of infants experienced hyperglycaemia, requiring the initiation or increase of insulin treatment during oral BTM treatment.